![[ACT EU Workplan for 2026-2027 – Version 4, May 2026]](https://cddf.org/wp-content/uploads/2026/05/Capture-1080x675.jpg)
Executive Summary: CDDF & AAADV Workshop – Challenges in the Landscape of a Global Development Strategy Including Patient Access (30-31 March 2026, BE)
The Cancer Drug Development Forum (CDDF) is delighted to announce that the executive summary of the CDDF & AAADV joint workshop on “Challenges in the Landscape of a Global Development Strategy Including Patient Access” has been published today. This...![[News from ACT EU] – Clinical Trials Information System (CTIS): training and support](https://cddf.org/wp-content/uploads/2026/04/Copy-of-PUBLICATION-Annual-Repport-2024-Is-available-4-1080x675.jpg)
[News from ACT EU] – Clinical Trials Information System (CTIS): training and support
Check out the publication of a new EMA document of frequently asked questions (FAQ) for sponsors on the Clinical Trials Information System (CTIS):...
Interim Report: ACT EU pilots on consolidated scientific and regulatory advice
The interim results from the ACT EU pilots on consolidated scientific and regulatory advice have been published and available to stakeholders. These pilots were launched to offer harmonised advice on how to improve the quality of applications for clinical trials and...![[CDDF NEW WHITE PAPER: Challenges and Potential Solutions to Advance Global Cancer Drug Development]](https://cddf.org/wp-content/uploads/2026/03/202603_Challenges-and-Potential-Solutions-to-Advance-Global-Cancer-Drug-Development-1080x675.jpg)